Process View
A developmental process, independent of morphogenetic (shape) change, that is required for an anatomical structure to attain its fully functional state.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "anatomical structure maturation"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| CDH1 | cadherin 1, type 1, E-cadherin (epithelial) | 0.592 | Human | |
| CSH1 | chorionic somatomammotropin hormone 1 (placental lactogen) | 0.502 | Human | |
| COPB1 | coatomer protein complex, subunit beta 1 | 0.476 | ||
| CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.384 | ||
| MSN | moesin | 0.343 | ||
| FSTL1 | follistatin-like 1 | 0.321 | ||
| BMPR1A | bone morphogenetic protein receptor, type IA | 0.271 | ||
| SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.255 | ||
| TCF3 | transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47) | 0.215 | ||
| CTNNA1 | catenin (cadherin-associated protein), alpha 1, 102kDa | 0.201 | ||
| CSH2 | chorionic somatomammotropin hormone 2 | 0.198 | Human | |
| PSEN1 | presenilin 1 | 0.174 | Mouse | |
| MAML1 | mastermind-like 1 (Drosophila) | 0.174 | ||
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.139 | ||
| ARHGEF11 | Rho guanine nucleotide exchange factor (GEF) 11 | 0.105 | ||
| RND1 | Rho family GTPase 1 | 0.104 | ||
| FLNC | filamin C, gamma | 0.103 | ||
| RBPJ | recombination signal binding protein for immunoglobulin kappa J region | 0.096 | Mouse | |
| SPEN | spen homolog, transcriptional regulator (Drosophila) | 0.085 | ||
| GH1 | growth hormone 1 | 0.080 | ||
| APP | amyloid beta (A4) precursor protein | 0.078 | ||
| FLNB | filamin B, beta | 0.077 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.075 | ||
| CEBPG | CCAAT/enhancer binding protein (C/EBP), gamma | 0.062 | ||
| COPB2 | coatomer protein complex, subunit beta 2 (beta prime) | 0.054 | ||
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.052 | ||
| UTRN | utrophin | 0.046 | ||
| SETD8 | SET domain containing (lysine methyltransferase) 8 | 0.045 | ||
| PTPRC | protein tyrosine phosphatase, receptor type, C | 0.042 | ||
| ATXN1L | ataxin 1-like | 0.040 | ||
| JUP | junction plakoglobin | 0.039 | ||
| PLXND1 | plexin D1 | 0.036 | ||
| ATF4 | activating transcription factor 4 (tax-responsive enhancer element B67) | 0.036 | ||
| ITGB1BP3 | integrin beta 1 binding protein 3 | 0.034 | ||
| TGFB3 | transforming growth factor, beta 3 | 0.033 | ||
| DSG2 | desmoglein 2 | 0.033 | ||
| CTNND1 | catenin (cadherin-associated protein), delta 1 | 0.031 | ||
| RUNX1 | runt-related transcription factor 1 | 0.031 | ||
| DMD | dystrophin | 0.031 | ||
| ENG | endoglin | 0.029 | ||
| GATA2 | GATA binding protein 2 | 0.026 | ||
| SGCG | sarcoglycan, gamma (35kDa dystrophin-associated glycoprotein) | 0.026 | ||
| APC | adenomatous polyposis coli | 0.026 | ||
| ARHGEF12 | Rho guanine nucleotide exchange factor (GEF) 12 | 0.025 | ||
| IGF2R | insulin-like growth factor 2 receptor | 0.024 | ||
| TGFB1 | transforming growth factor, beta 1 | 0.023 | Human | |
| APH1A | anterior pharynx defective 1 homolog A (C. elegans) | 0.023 | ||
| DNAJB2 | DnaJ (Hsp40) homolog, subfamily B, member 2 | 0.023 | ||
| TMED10 | transmembrane emp24-like trafficking protein 10 (yeast) | 0.022 | ||
| NCOR2 | nuclear receptor corepressor 2 | 0.022 | ||
| TIMP2 | TIMP metallopeptidase inhibitor 2 | 0.020 | ||
| CDK5 | cyclin-dependent kinase 5 | 0.020 | ||
| PKP4 | plakophilin 4 | 0.020 | ||
| SLC3A2 | solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2 | 0.018 | ||
| TUBB2B | tubulin, beta 2B | 0.018 | ||
| CSHL1 | chorionic somatomammotropin hormone-like 1 | 0.018 | Human | |
| ATXN1 | ataxin 1 | 0.018 | ||
| JUN | jun proto-oncogene | 0.016 | ||
| ATF3 | activating transcription factor 3 | 0.016 | ||
| PDX1 | pancreatic and duodenal homeobox 1 | 0.016 | ||
| CDH11 | cadherin 11, type 2, OB-cadherin (osteoblast) | 0.015 | ||
| SORBS1 | sorbin and SH3 domain containing 1 | 0.015 | ||
| DCTN1 | dynactin 1 | 0.014 | ||
| ARHGAP22 | Rho GTPase activating protein 22 | 0.014 | ||
| TGFBR1 | transforming growth factor, beta receptor 1 | 0.014 | ||
| BTRC | beta-transducin repeat containing | 0.014 | ||
| ARHGAP1 | Rho GTPase activating protein 1 | 0.014 | ||
| PLXNB2 | plexin B2 | 0.014 | ||
| SEMA6D | sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D | 0.013 | Human | |
| TCF7L2 | transcription factor 7-like 2 (T-cell specific, HMG-box) | 0.013 | ||
| JAG1 | jagged 1 | 0.013 | ||
| TCF4 | transcription factor 4 | 0.012 | ||
| GLIS2 | GLIS family zinc finger 2 | 0.012 | ||
| WFIKKN2 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 | 0.012 | ||
| FGFR2 | fibroblast growth factor receptor 2 | 0.012 | ||
| DBP | D site of albumin promoter (albumin D-box) binding protein | 0.012 | ||
| CAMK2A | calcium/calmodulin-dependent protein kinase II alpha | 0.012 | ||
| SH3RF1 | SH3 domain containing ring finger 1 | 0.011 | ||
| GH2 | growth hormone 2 | 0.011 | Human | |
| NOTCH1 | notch 1 | 0.010 | Mouse | |
| BMP2 | bone morphogenetic protein 2 | 0.010 | ||
| THBS2 | thrombospondin 2 | 0.010 |